Table 1.
General characteristics, atherosclerosis burden, acute phase management and medical treatments at discharge, grouped according to the depression status over a 9-month follow-up after ACS
| No Depression 71.3% | Depression 28.7% | |
|---|---|---|
| General characteristics | ||
| Mean Age ± sd (years) | 49.0 ± 8.8 | 52.2 ± 9.2 |
| Female gender (%) | 6.4 | 16.0 |
| Personal history of CV disease (%) | 8.1 | 16.0 |
| Family history of CV disease (%) | 17.7 | 28.0 |
| Personal history of depression (%) | 37.1 | 88.0 ** |
| Familial history of depression (%) | 25.8 | 20.0 |
| Live alone (%) | 17.7 | 24.0 |
| Widow(er)/divorcee/separated (%) | 45.1 | 48.0 |
| Low Socio-economic level (%) | 8.0 | 16.0 |
| Atherosclerosis Burden | ||
| Mean number of coronary vessels >50% stenosis | 1.4+/−0.8 | 1.6+/−0.6 |
| ABI < 0.9 (%) | 11 | 7 |
| Carotid stenosis >20% (%) | 18.6 | 22.2 |
| IMT > 0.7 mm (%) | 63 | 60 |
| ACS treatment | ||
| Revascularisation (%) | 91.9 | 92.0 |
| Conventional Treatment (%) | 8.1 | 8.0 |
| Post ACS medications at discharge | ||
| Beta-blocker and/or calcium antagonist | 96.7% | 96.0% |
| Cholesterol-lowering medication | 93.5% | 100.0% |
| Antiplatelet therapy or warfarin | 100.0% | 100.0% |
| ACE inhibitor or Angiotensin II receptor agonist | 100.0% | 96.0% |
| Combination of anti-ischemic/antiplatelet/Lipid-lowering drug | 90.3% | 96.0% |
*p values of tests comparing the “No depression” and “Depression” groups (Student’s t test for age, Chi square tests for proportions). * p < 0.05; ** p < 0.01.